Remove Assay Development Remove Pharmaceuticals Remove Screening Hits
article thumbnail

Biophysics

Sygnature Discovery

From hit finding and target engagement studies, to the characterisation of kinetic properties for late-stage candidate molecules, we believe that a biophysical approach complements other assays to deliver a fuller picture of binding behaviour to produce more effective therapeutics.

article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. Although we are an academic centre we work very much like industry.